Basic, clinically translational and human patient studies covering molecular targets and signaling mechanisms aimed to discover new therapeutic avenues for patients with cholestatic liver disease.

There continues to be ongoing need for effective therapies in MASLD. This session highlights treatment responses to available and approved therapeutics in MASLD.

Basic science talks that examine mechanisms of hepatic fibrosis and stellate cell biology